# Matthew Cohen

> Matthew Cohen is a Series C investor at Pangaea Ventures backing Pharmaceutical. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Pangaea Ventures](https://shizune.co/investors/profile/pangaea-ventures)
- Total investments: 1
- Last investment: Oct 2019
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/matthew-cohen-bb246532

Matthew Cohen is a Series C investor at Pangaea Ventures focused on Pharmaceutical and Advanced Materials. Matthew Cohen brings experience and a passion for working with advanced materials and cleantech in both industry and academia. Prior to joining Pangaea Ventures, Matthew worked in companies and ventures involved in printed electronics utilizing nanotechnology, biotechnology and environmental bioremediation. He performed various functions thatincluded business development, R&D, product development, customer technical support, and international launch strategies while gaining valuable start-up understanding.Matt holds an MPhil in Micro- & Nanotechnology Enterprise from the University of Cambridge and graduated summa cum laude from the University of Pennsylvania with a BSE in Materials Science & Engineering.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Pharmaceutical | 1 | 100% |
| Advanced Materials | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| TruTag Technologies | TruTag Technologies, Inc. is a leading authentication and technology solution provider serving businesses and governments around the world. TruTag has the most advanced precision-fabricated, cGMP nano-porous silica manufacturing operation in the world for product authentication across a broad range of industries including pharmaceuticals, food,consumer products, and industrial & electronic parts. TruTag’s authentication platform is complemented by its’ advanced hyperspectral imaging technology, which is focused on providing powerful next-generation inline quality assurance solutions and diagnostics.TruTag Technologies has been recognized by the SPIE Prism Awards, the Edison Awards, Fast Company, R&D 100, and was selected a Technology Pioneer by the World Economic Forum as one of the most influential technology companies in the world. |  | Series C | Oct 17, 2019 |  |

1 of 1 investments shown.

## Co-investors
- [Happiness Capital](https://shizune.co/investors/profile/happiness-capital) — VC Fund, 1 deal together
- [Polar Investment Fund, LLC](https://shizune.co/investors/profile/polar-investment-fund-llc) — VC Fund, 1 deal together
- [Presidio Ventures](https://shizune.co/investors/profile/presidio-ventures) — VC Fund, 1 deal together

## About Pangaea Ventures

VC Fund · Vancouver, Canada

Pangaea Ventures invests in companies solving fundamental problems in the world with advanced materials and hard technology; Impact Investor

5 contacts available at Pangaea Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Chris Erickson | General Partner | https://shizune.co/investors/profile/chris-erickson |
| Matthew Cohen | Associate | https://shizune.co/investors/profile/matthew-cohen |
| Purnesh Seegopaul | General Partner | https://shizune.co/investors/profile/purnesh-seegopaul |
| Tracy Hedberg | Director, Finance and Administration | https://shizune.co/investors/profile/tracy-hedberg |
| Andrew Haughian | General Partner | https://shizune.co/investors/profile/andrew-haughian |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Matthew Cohen invest in?

Matthew Cohen invests primarily in Pharmaceutical, Advanced Materials and Health Diagnostics startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Matthew Cohen last invest?

The most recent investment recorded for Matthew Cohen closed in Oct 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co